UNSPSC 51284109: Cefotaxime

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N2GI8B1GK7. European Medicines Agency schedules Cefotaxime in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07405MIG. Cefotaxime generally arises in the molecular formula C16H17N5O7S2.

UNSPSC 51284109 Cefotaxime is a Commodity code designating a specific antibiotic pharmaceutical product, but state and local governments have posted minimal recent activity under this code. The two recent opportunities tagged to this UNSPSC show substantial scope mismatch: the Illinois Department of Public Health's August 2026 piggyback pharmaceutical contract through MMCAP Infuse (awarded to Chartwell Rx LLC for $2,999,999.11 over three years with renewal options) procured Doxycycline Hyclate and Ciprofloxacin Hydrochloride, not Cefotaxime; Seminole County, Florida's June 2026 IFB solicited Naloxone and drug deactivation systems, unrelated to this code's scope. Neither opportunity reflects demand for Cefotaxime specifically, suggesting the code carries little or no current state and local procurement activity.

The mismatch between the code's nominal product (Cefotaxime, a third-generation cephalosporin antibiotic) and what state and local buyers are actually soliciting signals that this Commodity code may not be actively used in state and local procurement taxonomies, or that recent opportunities have been miscategorized. Firms monitoring this code should verify whether Cefotaxime procurement appears under parent Family or Class codes for pharmaceutical products and antibiotics more broadly, as state and local health departments, correctional agencies, and public hospitals do source antibiotics through consolidated purchasing agreements and piggyback contracts. Current visibility into actual Cefotaxime demand at the state and local level is insufficient to support a pursue decision based on this code alone.